Carl Zeiss Meditec continued its growth trend in the first six months of 2016/17.
Additionally for ophthalmic diagnostics, ZEISS presents its extensive diagnostic portfolio integrated with ZEISS FORUM.
At ARVO 2017, ZEISS demonstrates new Swept-Source OCT and OCT Angiography technology.
ZEISS recommends data backups and gives the majority of products the all-clear; patch updates are recommended for a few medical devices only
Diagnosis and treatment of eye diseases, including implants and consumables.
Diagnostic microscopes and solutions for digital visualization for gynecological applications.
Targeted intraoperative radiation therapy for cancer treatments of different tumor diseases.
ZEISS is one of the world’s leading suppliers of medical devices in the field of medical technology. It supplies innovative technologies and application-oriented solutions for ophthalmology and microsurgery designed to help doctors improve the quality of life of their patients.
ZEISS provides complete packages of solutions for diagnosis and devices for optical coherence tomography (OCT), perimetry, optical biometry and slit lamps. For the treatment of eye diseases ZEISS also offers not only ophthalmologic surgical microscopes, but also implants (intraocular lenses | IOLs) and consumables like ophthalmic viscosurgical devices (OVDs).
Within the field of microsurgery ZEISS creates innovative visualization solutions, especially surgical microscopes for minimally invasive surgeries. The medical technology portfolio is rounded off by promising, future-oriented technologies such as intraoperative radiotherapy.
Most of ZEISS’s medical technology activities are combined into Carl Zeiss Meditec AG, which is listed on TecDax of the German stock exchange. For more information, please click here.
